Real-time live intelligence — assembled from public and private sources on demand.
CMS surveys pharmacy acquisition costs weekly. See the latest numbers for the top 20 drugs by Medicare spending.
Explore pricing monitor →When PBMs charge plans more than pharmacies pay, the difference is profit. See how wide the gap is by drug class.
Analyze spreads →Track active and recruiting trials from ClinicalTrials.gov. Search by drug name to see what's in development.
Track pipeline →A drug's journey from Phase II through FDA approval to PBM formulary placement — and what it means for pricing.
View trials →The difference between what a PBM pays the pharmacy and what they charge the plan. See real data by drug class.
See spreads →Every number is sourced from live queries — combining federal databases with proprietary BuiltForAI network data. No estimates without disclosure.
Read methodology →Compare acquisition cost vs. reimbursement across drug classes. Model the impact on your organization.
Active and recruiting clinical trials, updated every 12 hours.
The 20 highest-cost drugs in the Medicare Part D program, with beneficiary counts and per-capita cost.